Coherent sees new laser as standard treatment for glaucoma:
This article was originally published in Clinica
In a pilot study of its new Selecta 7000 laser, Coherent found that it reduced the pressure associated with open-angle glaucoma by 30% on the first day of treatment, and that the benefit lasted for one year of follow-up. These initial results have encouraged the company to believe its technique, selective laser traberculoplasty, could become a standard treatment. The company is to begin shipment of the laser outside the US and will pursue clinical investigations in the US and Japan.